Breaking News Instant updates and real-time market news.

GPRO

GoPro

$9.83

0.02 (0.20%)

07:04
11/30/16
11/30
07:04
11/30/16
07:04

GoPro announces restructuring, workforce reduction of 15%

GoPro announced a company-wide restructuring that will reduce full-year 2017 non-GAAP operating expenses to approximately $650M (GAAP: $735M) and achieve its goal of returning to non-GAAP profitability in 2017. The restructuring includes the closure of its entertainment division, facilities reductions, and the elimination of more than 200 full-time positions plus the cancelation of open positions for a reduction in force of approximately 15%. Additionally, Tony Bates will depart his position as president of the company at the end of the year. "My time at GoPro has been an incredible experience," said Tony Bates. "In the past three years, GoPro has seen enormous progress in camera technology, software and international growth. Today GoPro has a solid leadership team deeply focused on its core business and profitability." GoPro estimates that it will incur total aggregate charges of approximately $24M-$33M for the restructuring, including approximately $13M-$18M of cash expenditures as a result of the workforce restructuring, substantially all of which are severance costs, and approximately $11M-$15M of non-cash expenditures, consisting primarily of stock-based compensation expense and accelerated depreciation associated with office consolidations. The company expects to recognize most of the restructuring charges in Q4 2016. "Consumer demand for GoPro is solid and we've sharply narrowed our focus to concentrate on our core business," said Nicholas Woodman. "We are headed into 2017 with a powerful global brand, our best ever products, and a clear roadmap for restored growth and profitability in 2017."

  • 30

    Nov

  • 05

    Dec

  • 07

    Dec

  • 12

    Dec

GPRO GoPro
$9.83

0.02 (0.20%)

11/09/16
RAJA
11/09/16
DOWNGRADE
RAJA
Market Perform
GoPro downgraded to Market Perform from Outperform at Raymond James
11/09/16
11/09/16
DOWNGRADE

Market Perform
GoPro downgraded to Market Perform after drone recall at Raymond James
As previously reported, Raymond James downgraded GoPro to Market Perform from Outperform following the company's announcement of an immediate recall of the roughly 2,500 Karma drones purchased since launch on October 23.. Analyst Tavis McCourt is concerned about GoPro's brand image following a 12-18 month period of product management missteps and its ability to broaden its product portfolio into different areas. McCourt didn't make any changes to 2016 estimates but is less comfortable in potential upside and sustainability of growth in 2017 and beyond.
11/09/16
DOTC
11/09/16
DOWNGRADE
DOTC
Sell
GoPro downgraded to Sell from Neutral at Dougherty
Dougherty downgraded GoPro to Sell from Neutral and lowered its price target to $6 following the drone recall. The analyst is concerned about management's multiple operational stumbles, weak Hero 5 demand, and elevated valuation.
11/09/16
11/09/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. JPMorgan (JPM) downgraded to Neutral from Outperform at Baird with analyst David George noting the stock's outperformance and the higher re-rating of its valuation multiple. 2. GoPro (GPRO) downgraded to Neutral from Outperform at Wedbush, to Market Perform from Outperform at Raymond James, and to Sell from Neutral at Dougherty. 3. Universal Health (UHS) downgraded to Neutral from Buy at BofA/Merrill, to Neutral from Buy at Mizuho, and to Market Perform from Outperform at Avondale. 4. Globus Medical (GMED) downgraded to Market Perform from Outperform at JMP Securities, to Perform from Outperform at Oppenheimer, and to Market Perform from Outperform at William Blair. 5. Delphi (DLPH) and Magna (MGA) were downgraded to Underperform from Buy at BofA/Merrill while the firm downgraded Lear (LEA), American Axle (AXL), Adient (ADNT), and BorgWarner (BWA) to Underperform from Neutral. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

15:05
06/23/17
06/23
15:05
06/23/17
15:05
General news
NY Fed's 3-day reverse repo totaled $201.5 B with 56 counterparties »

NY Fed's 3-day…

DAL

Delta Air Lines

$52.95

0.14 (0.27%)

15:03
06/23/17
06/23
15:03
06/23/17
15:03
Hot Stocks
Delta Air Lines, Korean Air create leading trans-Pacific joint venture »

Delta Air Lines and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 30

    Jun

  • 07

    Jul

XLV

Health Care Select Sector SPDR

$80.33

-0.26 (-0.32%)

, XLK

Technology Select Sector SPDR

$56.28

0.33 (0.59%)

14:59
06/23/17
06/23
14:59
06/23/17
14:59
Technical Analysis
On The Fly: Weekly technical notes for S&P 500 »

The S&P 500 (SPX) at…

XLV

Health Care Select Sector SPDR

$80.33

-0.26 (-0.32%)

XLK

Technology Select Sector SPDR

$56.28

0.33 (0.59%)

XLF

Financial Select Sector

$23.91

-0.07 (-0.29%)

XLE

Energy Select Sector SPDR

$64.16

0.21 (0.33%)

SPY

SPDR S&P 500 ETF Trust

$243.10

0.26 (0.11%)

SPX

S&P 500

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSN

Tyson Foods

$62.64

0.918 (1.49%)

14:57
06/23/17
06/23
14:57
06/23/17
14:57
Periodicals
Breaking Periodicals news story on Tyson Foods »

Hedgeye names Tyson Foods…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PAA

Plains All American

$24.53

0.6301 (2.64%)

14:50
06/23/17
06/23
14:50
06/23/17
14:50
Options
Bullish long-term option play opened in Plains All American Pipeline »

Bullish long-term option…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

  • 08

    Nov

LION

Fidelity Southern

$22.59

0.01 (0.04%)

14:46
06/23/17
06/23
14:46
06/23/17
14:46
Hot Stocks
Fidelity Southern announces appointment of Charles Christy as CFO »

Fidelity Southern…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

14:40
06/23/17
06/23
14:40
06/23/17
14:40
General news
Fedspeak will resume with Chair Yellen »

Fedspeak will resume with…

14:30
06/23/17
06/23
14:30
06/23/17
14:30
Options
Alerian MLP attracts call buyers as shares attempt to rebound »

Alerian MLP attracts call…

LITE

Lumentum

$62.45

-0.05 (-0.08%)

14:25
06/23/17
06/23
14:25
06/23/17
14:25
Options
Lumentum call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 12

    Jul

  • 13

    Jul

14:20
06/23/17
06/23
14:20
06/23/17
14:20
General news
Action Economics Survey results »

Action Economics Survey…

NTDOY

Nintendo

$42.05

0.435 (1.05%)

, SNE

Sony

$38.52

0.11 (0.29%)

14:17
06/23/17
06/23
14:17
06/23/17
14:17
Periodicals
Nintendo market cap surpasses Sony's in Japan, Nikkei reports »

Nintendo's (NTDOY)…

NTDOY

Nintendo

$42.05

0.435 (1.05%)

SNE

Sony

$38.52

0.11 (0.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

14:17
06/23/17
06/23
14:17
06/23/17
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

14:16
06/23/17
06/23
14:16
06/23/17
14:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PTLA

Portola Pharmaceuticals

$38.25

-1.24 (-3.14%)

14:15
06/23/17
06/23
14:15
06/23/17
14:15
Conference/Events
Portola Pharmaceuticals hold a conference call »

Management holds a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jun

  • 24

    Jun

SAFM

Sanderson Farms

$123.21

-2.89 (-2.29%)

14:08
06/23/17
06/23
14:08
06/23/17
14:08
Hot Stocks
Sanderson Farms to 'vigorously defend' California chicken lawsuit »

Sanderson Farms issued a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RH

RH

$60.50

3.847 (6.79%)

14:05
06/23/17
06/23
14:05
06/23/17
14:05
Options
Restoration Hardware call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:00
06/23/17
06/23
14:00
06/23/17
14:00
General news
Breaking General news story  »

Federal Reserve Board…

BLCM

Bellicum Pharmaceuticals

$13.98

1.33 (10.51%)

13:51
06/23/17
06/23
13:51
06/23/17
13:51
Recommendations
Bellicum Pharmaceuticals analyst commentary  »

Bellicum selloff after…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jun

  • 26

    Sep

MDRX

Allscripts

$12.71

0.52 (4.27%)

13:50
06/23/17
06/23
13:50
06/23/17
13:50
Options
Second day of bullish option flow in Allscripts »

Second day of bullish…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NTNX

Nutanix

$18.50

0.16 (0.87%)

13:45
06/23/17
06/23
13:45
06/23/17
13:45
Options
Nutanix call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:40
06/23/17
06/23
13:40
06/23/17
13:40
General news
And now Fed's Mester warns that a failure to hike »

And now Fed's Mester…

PTLA

Portola Pharmaceuticals

$38.25

-1.24 (-3.14%)

13:36
06/23/17
06/23
13:36
06/23/17
13:36
Hot Stocks
Breaking Hot Stocks news story on Portola Pharmaceuticals »

Portola Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jun

  • 24

    Jun

PTLA

Portola Pharmaceuticals

$38.25

-1.24 (-3.14%)

13:35
06/23/17
06/23
13:35
06/23/17
13:35
Hot Stocks
Breaking Hot Stocks news story on Portola Pharmaceuticals »

Portola Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jun

  • 24

    Jun

GE

General Electric

$27.59

0.035 (0.13%)

13:30
06/23/17
06/23
13:30
06/23/17
13:30
Options
19.1K GE Jul - Aug 29 call spreads sold at 12c »

19.1K GE Jul - Aug 29…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

PTLA

Portola Pharmaceuticals

$38.25

-1.24 (-3.14%)

13:26
06/23/17
06/23
13:26
06/23/17
13:26
Hot Stocks
Portola Pharmaceuticals to resume trading at 1:35 pm ET »

Portola Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jun

  • 24

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.